Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 30 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Vardaka, Elisabeth [Clear All Filters]
Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome..
J Neurogastroenterol Motil. 29(3), 403-404.
(2023). Controlling the Impact of -Related Hyperhomocysteinemia on Neurodegeneration..
Medicina (Kaunas). 59(3),
(2023). Impact of nonalcoholic fatty liver disease-related metabolic state on depression..
Neurochem Int. 163, 105484.
(2023). Innate immunity and nonalcoholic fatty liver disease..
Ann Gastroenterol. 36(3), 244-256.
(2023). Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels..
Aliment Pharmacol Ther. 58(11-12), 1252-1253.
(2023).
(2023).
(2023).
(2022).
Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection..
Intern Med J. 52(9), 1654-1655.
(2022). GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection..
Helicobacter. 27(3), e12884.
(2022). Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension..
Arq Bras Cardiol. 119(3), 502-504.
(2022). Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al..
Obes Surg. 32(6), 2079-2080.
(2022). Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease..
Metabolism. 135, 155276.
(2022). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022). Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease..
Minerva Endocrinol (Torino).
(2021). Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction..
J Neurogastroenterol Motil. 27(1), 147-148.
(2021). Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension..
Microorganisms. 9(11),
(2021). Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders..
J Neurogastroenterol Motil. 27(4), 653-654.
(2021). The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis..
Neurochem Int. 144, 104938.
(2021). Helicobacter pylori infection as a potential risk factor for multiple sclerosis..
Med Hypotheses. 143, 110135.
(2020). Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap..
J Clin Gastroenterol. 54(2), 200-201.
(2020). The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders..
J Neurogastroenterol Motil.
(2019). The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies..
Scand J Gastroenterol. 1-2.
(2019). A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration..
Neurochem Int. 113, 137-151.
(2018).
(2017).